Trailing-twelve-month (TTM) revenue is $4.26 Billion with a year-over-year growth of +27.21%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2026Period ended 2025-11-02 | $964,453,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-10 |
| Q4 FY2026Period ended 2026-02-01 | $1,058,903,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-25 |
| Q1 FY2027Period ended 2026-05-03 | $1,052,896,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-05 |
| Q2 FY2027Period ended 2026-08-02 | $1,185,898,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-04 |
| TTM revenue | $4,262,150,000 |
Current P/S: $36,853,742,350 market capitalization ÷ $4,262,150,000 TTM revenue = 8.65x.
Market capitalization source: FMP quote. Quote observed 2026-09-22T19:59:59.000Z. Latest revenue period ended 2026-08-02.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2027 (2026-08-02): $1.19B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T09:01:19.823Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-02-01 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-02-01 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-02-06 · USD | FY20232023-02-05 · USD | FY20242024-02-04 · USD | FY20252025-02-02 · USD | FY20262026-02-01 · USD |
|---|---|---|---|---|---|---|
| Product | N/A | $1.4B | $1.8B | $1.6B | $1.7B | $2.0B |
| Product Revenue And Support Subscription Revenue | $557M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-02-06 · USD | FY20232023-02-05 · USD | FY20242024-02-04 · USD | FY20252025-02-02 · USD | FY20262026-02-01 · USD |
|---|---|---|---|---|---|---|
| Non-US | $489M | $601M | $782M | $851M | $961M | $1.2B |
| UNITED STATES | $1.2B | $1.6B | $2.0B | $2.0B |
$4.26B
$4.26 Billion
+27.21%
vs. $3.35B a year ago (TTM)
+18.51%
5 Year compound annual growth rate
1 Year
+27.21%
3 Year
+14.84%
5 Year
+18.51%
10 Year
+21.96%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $3.66B | +$494.68M | +15.61% |
| 2025 | $3.17B | +$337.54M | +11.92% |
| 2024 | $2.83B | +$77.19M | +2.80% |
| 2023 | $2.75B | +$572.59M | +26.26% |
| 2022 | $2.18B | +$496.67M | +29.49% |
| 2021 |
TTM Growth
+27.21%
3-Year CAGR
+14.84%
5-Year CAGR
+18.51%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T09:01:19.823Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Service | N/A | $739M | $961M | $1.2B | $1.5B | $1.7B |
|---|
| $2.5B |
| $1.68B |
| +$40.74M |
| +2.48% |
| 2020 | $1.64B | +$283.62M | +20.86% |
| 2019 | $1.36B | +$335.06M | +32.70% |
| 2018 | $1.02B | +$285.59M | +38.64% |
| 2017 | $739.17M | +$298.84M | +67.87% |
